血液凝固 血液の凝固
1Department of Clinical Chemistry, Lund University, University Hospital, Malmö, Sweden. bjorn.dahlback@klkemi.mas.lu.se
Lancet (London, England)
|May 23, 2000
まとめ
凝固系は,抗凝固を好むバランスを保ちます. ビタミンKアンタゴニスト,ヘパリン,遺伝子療法の理解は,凝固障害と欠乏症の管理に関する洞察を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 血液学 ヘマトロジ
- 分子生物学は分子生物学である.
背景:
- 凝固系は通常,抗凝固を好みます.
- トロンビンは,凝固カスケードの中心的な酵素です.
- ビタミンKに依存した変異は凝固タンパク質の機能に不可欠である.
研究 の 目的:
- 凝固システムのバランスを再検討する.
- 抗凝固のメカニズムについて議論します.
- 凝固障害に対する治療の選択肢を探求する.
主な方法:
- 凝固カスケードと規制メカニズムの見直し.
- ビタミンKアンタゴニストとヘパリンについての議論.
- 凝固因子に対するノックアウトマウスモデルの分析.
- 遺伝的欠陥に対する遺伝子療法の検討.
主要な成果:
- ビタミンKアンタゴニストは,タンパク質の改変を妨害する.
- ヘパリンは,抗トロンビン活性を増強する.
- ノックアウトマウスは,凝固因子のインビボの重要性を明らかにしています.
- 遺伝子治療は,因子VIIIとIXの欠乏症に対して有望な効果を示しています.
結論:
- 凝固システムは厳格に規制されています.
- ビタミンKアンタゴニストやヘパリンなどの薬剤は凝固を調節する.
- 遺伝子療法などの遺伝的アプローチは,遺伝的出血障害の将来の治療の可能性を提供します.
さらに関連する動画
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
関連する概念動画
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:15Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...